'US industry reviewing Supreme Court decision on Novartis'
April 03, 2013  11:24
The US industry today said it is reviewing the order of the Supreme Court early this week that denied patent on Glivec, a cancer medication produced by Swiss drug maker Novartis, as Corporate America expressed dismay at the court verdict. 

"We are aware of the Supreme Court decision and are reviewing the Court's order," the US Trade Representative spokesperson Andrea Mead told PTI.

"We look forward to continued engagement and successful collaboration with India on these issues," Mead said when asked on the US position on the Supreme Court decision.
« Back to LIVE

TOP STORIES